NTRP Market Cap History
Below is a table of the NTRP market cap history going back to 3/6/2017:

Date NTRP Market Cap
3/6/2017145.25M
3/29/2017137.80M
5/10/201764.06M
8/4/201731.19M
10/30/201733.00M
2/28/201868.56M
5/4/201871.09M
8/10/201875.93M
10/28/201853.31M
2/28/201962.80M
5/7/201987.61M
8/2/201964.59M
1/14/2019239.48M

Also see: NTRP Shares Outstanding History
and NTRP YTD Return
NTRP Historical Market Cap:
+30.84% CAGR
NTRP Historical Market Cap: +30.84% CAGR

Mouse over chart for data details
3/6/2017 ...1/14/2019
Neurotrope is a biopharmaceutical company with product candidates in pre-clinical and clinical development. Co. is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. Co. is also developing bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease. In addition, Co. is also in the early stages of testing bryostatin activity which may lead to applications in Leukemia and Lymphoma. We show 13 historical shares outstanding datapoints in our NTRP shares outstanding history coverage, used to compute NTRP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NTRP market cap history over the course of time is important for investors interested in comparing NTRP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NTRP versus a peer is one thing; comparing NTRP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NTRP can fluctuate over the course of history. With this page we aim to empower investors researching NTRP by allowing them to research the NTRP market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for NTRP:
NTRP SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neurotrope (NTRP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NURO Market Cap History
NUVA Market Cap History
NVAX Market Cap History
NVIV Market Cap History
NVO Market Cap History
NVRO Market Cap History
NVTA Market Cap History
NVTR Market Cap History
NVUS Market Cap History
NXTM Market Cap History
More Healthcare companies »

 

NTRP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.